Skip to content

Evaluation of Licorice Root on Metabolic Syndrome in Polycystic Ovary Syndrome Females

Effect of Licorice Root Powder on Parameters of Metabolic Syndrome Related to Polycystic Ovary Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06043375
Enrollment
55
Registered
2023-09-21
Start date
2024-02-01
Completion date
2024-06-05
Last updated
2024-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome, Polycystic Ovary Syndrome

Keywords

Licorice, Metabolic Syndrome, Polycystic Ovary Syndrome, Licorice Root Powder

Brief summary

The goal of this study is to learn about the effect of licorice root powder on parameters of metabolic syndrome in those women diagnosed with PCOS with age range of 15-49 years of age. The study aims to answer the following questions: * Will licorice root powder consumption will have an impact on parameters of metabolic syndrome which are HDL levels, triglycerides, fasting blood pressure and blood glucose levels and abdominal obesity related to PCOS. * Will licorice help in lowering stress scores and improve quality of life. Females with diagnosed PCOS will be recruited in the study and will be randomly allotted to two groups. One group will be intervention group and second will be control group. Participants in intervention group will be given 1000mg of licorice root powder in form of capsules (1 per day). Control group will not take anything. For both groups, SF-12 health survey, and readings of lipid profile, fasting blood glucose and blood pressure and central obesity will be taken. Researcher will compare readings of both groups at baseline and after 3 months of intervention to assess the effect of licorice root powder.

Detailed description

Polycystic ovary syndrome (PCOS) is an endocrine disorder which is characterized by ovarian cyst, irregular menses and elevated androgen levels whereas metabolic syndrome (metS) includes presence of 3 out of 5 conditions which are abdominal obesity, high blood glucose levels, high blood pressure, high triglyceride levels and low HDL levels. Metabolic syndrome and polycystic ovary syndrome have a two-way relationship. The risk of development of metS in PCOS females is five-fold higher than non-PCOS females. If PCOS is not addressed timely then it can lead to infertility. Herbal treatments and ayurvedic medicine is thought to be effective in treating PCOS. A lot of data is available which shows positive results using herbs like cinnamon, aloevera etc but data on licorice root powder is limited. Licorice is one of the oldest herb and has anti-inflammatory, antidiabetic, antiobesity, hypolipidemic and so many other properties which makes it very useful herb. The objective of this study is to evaluate antidiabetic, hypolipidemic and anti-inflammatory properties of licorice root powder on metabolic syndrome related to PCOS. The study will also observe effect of licorice on stress levels using SF-12 questionnaire. The study will be conducted in seven steps. Step 1 is the preparation of licorice root powder capsules. Step 2 is recruitment of participants. Participants will be recruited from universities and hospitals after checking their ultrasound report or diagnosis of PCOS by doctor. Step 3 is dividing the participants into two groups which are control and intervention group based on randomization. Step 4 is conduction of baseline testing of both groups of abdominal obesity, TGL, HDL, BGL, BP and stress levels. Step 5 is administration of capsules for 3 months. Step 6 is post-interventional testing. Similar tests will be done as baseline testing. Step 7 is data analysis. Data will be analyzed using SPSS software and paired sample t test will be used for results interpretation.

Interventions

DIETARY_SUPPLEMENTLicorice Root Powder Capsule

Fresh licorice root will be obtained from local market of Lahore. The root will be washed and dried at room temperature. Then it will be converted into powder using grinder. After sieving the ground powder, it will be filled in capsules. One capsule will contain 1000mg of powder. Participants in experimental group will be instructed to consume one capsule per day.

Sponsors

University of Veterinary and Animal Sciences, Lahore - Pakistan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants will be randomly allotted to two groups. One group will receive licorice root powder capsules while the other group will not receive any treatment

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 49 Years
Healthy volunteers
No

Inclusion criteria

* Females with diagnosed PCOS

Exclusion criteria

* Hypertension * Cardiovascular diseases * Pregnancy * Any sort of allergy * Skin problems * Females without diagnosed PCOS

Design outcomes

Primary

MeasureTime frameDescription
Change in fasting blood glucose levelsChange from baseline fasting levels at 3 monthsFasting blood glucose levels will be measured using glucometer at 8-10 hours of fasting.
Change in fasting blood pressure levelsChange from baseline fasting levels at 3 monthsFasting blood pressure levels will be measured using sphygmomanometer at 8-10 hours of fasting.
Change in HDL and triglycerides levelsChange from baseline levels at 3 monthsHDL and triglycerides levels will be measured by taking blood sample and running tests in laboratory.
Change in abdominal obesity measurement at week 12Change from baseline measurement at 3 monthsAbdominal obesity will be assessed using waist circumference measurements. An inches tape will be used to measure waist circumference (normal is less than 80 cm).

Secondary

MeasureTime frameDescription
Change in stress levelsChange from baseline test scores at 3 monthsA questionnaire will be used to assess stress levels. SF-12 Health Survey is a validated questionnaire used to assess patients reviews about their health and assessing stress levels using scores. It contains 12 questions.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026